Rsv Vaccine Pref3, Recombinant Dosage

Medically reviewed by Drugs.com. Last updated on Aug 8, 2023.

Applies to the following strengths: preservative-free 120 mcg

Usual Adult Dose for:

Respiratory Syncytial Virus

Additional dosage information:

Renal Dose Adjustments
Liver Dose Adjustments
Precautions
Dialysis
Other Comments

Usual Adult Dose for Respiratory Syncytial Virus

0.5 mL IM as a single dose.

Uses:

For active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals aged 50 to 59 years with an increased risk of LRTD caused by RSV
For active immunization for the prevention of lower respiratory tract disease LRTD caused by respiratory syncytial virus RSV individuals 60 years of age and older.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS: History of severe allergic reaction to any component of the vaccine.

Safety and efficacy have not been established in patients younger than 50 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

For IM administration only.

Storage requirements:

Administer immediately or store in the refrigerator between 2C and 8C (36F to 46F) or at room temperature for up to 4 hours prior to use.
Protect vials from light.
Discard reconstituted vaccine if not used within 4 hours.
Do not freeze. Discard if the vaccine is frozen.

Reconstitution/preparation techniques:

The manufacturer's product information should be consulted.

Patient advice:

Read Vaccine Information Statement (VIS) provided or available at (www.cdc.gov/vaccines).
Discuss and report possible adverse reactions with the healthcare provider.